Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-05-31
1997-05-27
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514252, 544229, 544370, 544384, 540485, 540487, 540575, 5483411, 5483415, 5483431, A61K 3155, A61K 31495, C07D40306
Patent
active
056332505
ABSTRACT:
Disclosed us a compound of Formula 1.0: ##STR1## or a pharmaceutically acceptable salt or solvate thereof. Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier and an effective amount of a Compound of Formula 1.0.
Further disclosed is a method of treating allergy (for example asthma), inflammation, hypertension, raised intraocular pressure (such as glaucoma)--i.e., a method of lowering intraocular pressure, sleeping disorders, states of hyper and hypo motility and acidic secretion of the gastrointestinal tract, hypo and hyperactivity of the central nervous system (for example, agitation and depression) and other CNS disorders (such as Alzheimers, Schizophrenia, and migraine) comprising administering an effective amount of a compound of Formula I to a patient in need of such treatment.
REFERENCES:
patent: 3491098 (1970-01-01), Archer
patent: 4404382 (1983-09-01), Gall
patent: 4404438 (1983-09-01), Gall
patent: 4431387 (1984-02-01), Wei et al.
patent: 4767778 (1988-08-01), Arrang et al.
patent: 4935417 (1990-06-01), Pascal et al.
patent: 5010075 (1991-04-01), Pascal et al.
patent: 5071859 (1991-12-01), Knudsen et al.
patent: 5091428 (1992-02-01), Pascal et al.
patent: 5276034 (1994-01-01), Pascal et al.
patent: 5342960 (1994-08-01), Garbara et al.
patent: 5463074 (1995-10-01), Shih et al.
West Jr. et al., Journal of Neurochemistry, vol. 55, No. 5, pp. 1612-1616 (1990).
West Jr. et al, Molecular Pharmacology, 38:610-613 (1990).
Korte et al., Biochemical and Biophysical Research Communications, vol. 168, No. 3, pp. 979-986 (1990).
Derwent Abstract 86-273706/42 for EP 0 197 840 (Oct. 1986).
Derwent Abstract 90-184730/24 for US 4 925 851 (May 1990).
Derwent Abstract 90-180087/24 for EP 372 125 (Jun. 1990).
Derwent Abstract 88-309195/44 for US 4 935 417 (Jun. 1990).
Appel, Current Neurology, vol. 6, pp. 289, 313-316, (1987) ("Alzheimer's Disease").
Schunack CA 80(15): 82801a (1973).
Bernhardt Emily
Jeanette Henry C.
Schering Corporation
LandOfFree
Imidazoylalkyl substituted with a six or seven membered heterocy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoylalkyl substituted with a six or seven membered heterocy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoylalkyl substituted with a six or seven membered heterocy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2329228